000 | 01221 a2200325 4500 | ||
---|---|---|---|
005 | 20250516181127.0 | ||
264 | 0 | _c20140623 | |
008 | 201406s 0 0 eng d | ||
022 | _a1744-8379 | ||
024 | 7 |
_a10.1586/14737167.2013.851006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTaylor, Robert | |
245 | 0 | 0 |
_aEconomic implications of potential drug-drug interactions in chronic pain patients. _h[electronic resource] |
260 |
_bExpert review of pharmacoeconomics & outcomes research _cDec 2013 |
||
300 |
_a725-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAnalgesics, Opioid _xadverse effects |
650 | 0 | 4 |
_aChronic Pain _xdrug therapy |
650 | 0 | 4 |
_aDelivery of Health Care _xeconomics |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPolypharmacy |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aV Pergolizzi, Joseph | |
700 | 1 | _aPuenpatom, R Amy | |
700 | 1 | _aSummers, Kent H | |
773 | 0 |
_tExpert review of pharmacoeconomics & outcomes research _gvol. 13 _gno. 6 _gp. 725-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737167.2013.851006 _zAvailable from publisher's website |
999 |
_c23255043 _d23255043 |